Results of a new multicenter study found that vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine reduced the risk of COVID-19-associated hospitalizations in children ages 5-11 years by two-thirds during the Omicron period.
© Ann & Robert H. Lurie Children's Hospital of Chicago